Clinical Trial Update: Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a PD-1 inhibitor in combination with neoadjuvant chemotherapy for advanced endometrial cancer (endometrioid subtype); the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Endometrioid Endometrial Cancer | Phase 2 | Status: RECRUITING